Mar/Apr 2024 - Volume 28, Number 2

Purchase or view individual articles by selecting the article in the table below...

Individual Articles - Mar/Apr 2024 - Volume 28, Number 2

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2024 Pg. 92	Prescription: Compounding for Pain Management Patients Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 94-98	Magic Mouthwashes- A Literature Review and Discussion of Common Compositions Author(s): McElhiney Linda F
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2024 Pg. 111-116	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024 Pg. 118-119	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Mar/Apr 2024 Pg. 120-127	Sterile Filtration Author(s): Akers Michael J
Mar/Apr 2024 Pg. 128-129	Calculations: Isotonic Solution Potency Range and Solubility Calculations Author(s): Stockton Shelly J
Mar/Apr 2024 Pg. 129	Addendum to Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine A New Therapeutic Modality Author(s):
Mar/Apr 2024 Pg. 130	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 131	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 132	Analgesic Compound Lotion, Clear Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 133	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 134	Diclofenac Sodium 1% Soft-patch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 135	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 136	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 137	Rectal Rockets: Lidocaine 3%, Hydrocortisone 2% Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 138-145	Hydrophilic Ready-to-use Vehicles and Compounded Topical Medications Author(s): Spennacchio Antonio, Lacassia Chiara, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2024 Pg. 146-150	Lipophilic Ready-to-use Vehicles and Compounded Topical Medications Author(s): Lacassia Chiara, Spennacchio Antonio, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2024 Pg. 151-155	Physical-chemical Stability of the Extemporaneous Paracetamol Oral Suspension in Puccini Base Author(s): Lacassia Chiara, Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
Mar/Apr 2024 Pg. 156-160	Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro™ Cream Base, VersaPro™ Gel Base and PLO Gel Mediflo™ 30 Compound Kit Author(s): Friciu Mihaela, Cull Erica, Haiub Halema, Lupatini Rodrigo, Leclair Grégoire
Mar/Apr 2024 Pg. 161-168	Compatibility of Caffeine Clobetasol Propionate Dutasteride Nicotinamide and Progesterone in TrichoFoam™, a Natural Vehicle for Hair Foams Author(s): Polonini Hudson C, de Sousa Pamela Lopes, Silva Carolina CV, Marianni Bruna
Mar/Apr 2024 Pg. 169-175	Clinical Safety Profile of TrichoConcept™, a Line of Cosmetic Vehicles for Personalized Treatment of Alopecia Author(s): Marianni Bruna, Polonini Hudson, Silva Carolina